Regeneron Pharmaceuticals, Inc.

FIRST TRUST ADVISORS LP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

205,732

Value ($000)

158,799

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	158,799	0.1%	205,732	12/31/2025
2025 Q3	11/12/2025	111,474	0.1%	198,257	9/30/2025
2025 Q2	8/13/2025	96,623	0.1%	184,044	6/30/2025
2025 Q1	5/14/2025	72,251	0.1%	113,920	3/31/2025
2024 Q4	2/13/2025	194,175	0.2%	272,592	12/31/2024
2024 Q3	11/13/2024	306,900	0.3%	291,941	9/30/2024
2024 Q2	8/13/2024	380,793	0.4%	362,305	6/30/2024
2024 Q1	5/13/2024	323,851	0.3%	336,472	3/31/2024
2023 Q4	2/13/2024	321,410	0.4%	365,950	12/31/2023
2023 Q3	11/13/2023	139,943	0.2%	170,048	9/30/2023
2023 Q2	8/14/2023	116,129	0.1%	161,618	6/30/2023
2023 Q1	5/15/2023	183,787	0.2%	223,675	3/31/2023
2022 Q4	2/9/2023	144,067	0.2%	199,680	12/31/2022
2022 Q3	11/14/2022	312,255	0.4%	453,287	9/30/2022
2022 Q2	8/12/2022	235,607	0.3%	398,571	6/30/2022
2022 Q1	5/13/2022	120,739	0.1%	172,875	3/31/2022
2021 Q4	2/8/2022	128,632	0.1%	203,687	12/31/2021
2021 Q3	11/15/2021	119,655	0.1%	197,718	9/30/2021
2021 Q2	10/12/2021	96,209	0.1%	172,250	6/30/2021
2021 Q1	5/14/2021	82,353	0.1%	174,057	3/31/2021
2020 Q4	2/2/2021	78,226	0.1%	161,921	12/31/2020
2020 Q3	11/5/2020	203,839	0.3%	364,142	9/30/2020
2020 Q2	7/22/2020	223,928	0.4%	359,061	6/30/2020
2020 Q1	5/6/2020	122,204	0.3%	250,269	3/31/2020
2019 Q4	2/3/2020	115,105	0.2%	306,554	12/31/2019
2014 Q2	8/11/2014	79,785	0.3%	282,454	6/30/2014
2014 Q1	5/12/2014	77,014	0.3%	256,473	3/31/2014
2013 Q4	8/8/2014	78,640	0.4%	285,714	12/31/2013